Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands
Alí N. Kamali, José M. Bautista, Michael Eisenhut, et al.
Therapeutic Advances in Vaccines and Immunotherapy (2023) Vol. 11
Open Access | Times Cited: 18

Showing 18 citing articles:

The Relationship between Circadian Rhythm and Cancer Disease
Camelia Munteanu, Sabina Turti, Larisa Achim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5846-5846
Open Access | Times Cited: 11
Didemnins as marine-derived anticancer agents: mechanistic insights and clinical potential
Muhammad Asif Ali, Azmat Ullah, Ahmad Ali, et al.
Medical Oncology (2025) Vol. 42, Iss. 2
Closed Access | Times Cited: 1
Hyperoside Inhibits RNF8-mediated Nuclear Translocation of β-catenin to Repress PD-L1 Expression and Prostate Cancer
Jie Chen, Y. Zhao, Xiaoli Wang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 6, pp. 464-476
Closed Access | Times Cited: 4
Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy
Y Zeng, Qing Gu, Dan Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 12, pp. 2455-2473
Closed Access | Times Cited: 4
LAG‐3—An incompletely understood target in cancer therapy
Judith Leitner, Katharina Radakovics, Peter Steinberger
The FASEB Journal (2024) Vol. 38, Iss. 22
Open Access | Times Cited: 4
The Efficacy of Curcumin in Reducing Immunosuppressive States of Peripheral Blood Mononuclear Cells Extracted From Oral Squamous Cell Carcinoma Patients: An In Vitro Study
Prakruti Dash, Saurav Nayak, Pradipta Kumar Parida
Cureus (2025)
Open Access
Monoclonal antibodies – A repertoire of therapeutics
Suman Tapryal
Advances in protein chemistry and structural biology (2025), pp. 151-212
Closed Access
Peptide-driven strategies against lung cancer
Vijayshree S Karankar, Saurabh Awasthi, Nidhi Srivastava
Life Sciences (2025), pp. 123453-123453
Closed Access
Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-expressing platelets in patients with lung cancer
Sung‐Woo Lee, Saei Jeong, Young Ju Kim, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010193-e010193
Open Access
Immune inhibitory receptor agonist therapeutics
Rustin R. Lovewell, Solomon Langermann, Dallas B. Flies
Frontiers in Immunology (2025) Vol. 16
Open Access
CAR T Cells in Lung Cancer: Targeting Tumor-Associated Antigens to Revolutionize Immunotherapy
Sattam Khulaif Alenezi
Pathology - Research and Practice (2025), pp. 155947-155947
Closed Access
Gynecological cancer tumor Microenvironment: Unveiling cellular complexity and therapeutic potential
Pankaj Garg, Sravani Ramisetty, Ayalur Raghu Subbalakshmi, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116498-116498
Closed Access | Times Cited: 2
Synthetic and biological nanoparticles for cancer immunotherapy
Inês Oliveira, Paulo Rodrigues‐Santos, Lino Ferreira, et al.
Biomaterials Science (2024) Vol. 12, Iss. 23, pp. 5933-5960
Closed Access | Times Cited: 1
Pipeline for Assessing Tumor Immune Status Using Superplex Immunostaining and Spatial Immune Interaction Analysis
Chaoxin Xiao, Ruihan Zhou, Qin Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Can tissue-specific PD-1/PD-L1 targeting combined with other immune checkpoint blockades enhance immune clearance?
Sadia Ahmad, Amna Rehman, Ali Afzal, et al.
Medical Hypotheses (2024), pp. 111491-111491
Closed Access
Immune Checkpoints and Graves’ Disease, Thyroid Eye Disease, and Orbital Myopathy: A Comprehensive Review
Zahra Souri, Farzad Pakdel
Journal of Ophthalmic and Vision Research (2024)
Open Access
Multiple myeloma and the potential of new checkpoint inhibitors for immunotherapy
Alí N. Kamali, Haleh Hamedifar, Michael Eisenhut, et al.
Therapeutic Advances in Vaccines and Immunotherapy (2024) Vol. 12
Open Access
TRPC6 is a Biomarker for Prognosis and Immunotherapy of Stomach Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation
Xingchi Hu, Hongwei Wang, Haitao Sun, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 735-748
Open Access
Page 1

Scroll to top